![Jun Yoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jun Yoon
Fondateur chez
STRUCTURE THERAPEUTICS INC.
Fortune : 28 M $ au 30/09/2026
Profil
Jun Yoon is the founder of Structure Therapeutics, Inc., founded in 2019, serving as Chief Financial Officer.
Mr. Yoon currently works at Shanghai ShouTi Biotechnology Co. Ltd. as Chief Operating Officer & Director.
Former jobs include Senior Director-Licensing & Business Development at VIA Pharmaceuticals, Inc. from 2004 to 2010, Head-Business Development at Syrrx, Inc. from 2000 to 2002, and Vice President-Corporate Development at Cellerant Therapeutics, Inc. from 2010 to 2016.
Education includes undergraduate studies at the University of California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 2 683 830 ( 1,92 % ) | 28 M $ | 30/09/2026 |
Postes actifs de Jun Yoon
| Sociétés | Poste | Début |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Fondateur | 01/02/2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Directeur des opérations | - |
Anciens postes connus de Jun Yoon
| Sociétés | Poste | Fin |
|---|---|---|
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Corporate Officer/Principal | 01/01/2016 |
| VIA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2010 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Corporate Officer/Principal | 01/10/2002 |
Formation de Jun Yoon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer | Health Technology |
VIA Pharmaceuticals, Inc.
 VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
